These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15467753)

  • 1. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
    Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
    Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation.
    Voltz JW; Weinman EJ; Shenolikar S
    Oncogene; 2001 Oct; 20(44):6309-14. PubMed ID: 11607833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
    Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
    Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y; Wang L; Dai JL
    Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epithelial brush border Na+/H+ exchanger NHE3 associates with the actin cytoskeleton by binding to ezrin directly and via PDZ domain-containing Na+/H+ exchanger regulatory factor (NHERF) proteins.
    Cha B; Donowitz M
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):863-71. PubMed ID: 18430067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
    Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
    Yuan Y; Mendez R; Sahin A; Dai JL
    Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
    Li J; Sidell N
    Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange.
    Weinman EJ; Wang Y; Wang F; Greer C; Steplock D; Shenolikar S
    Biochemistry; 2003 Nov; 42(43):12662-8. PubMed ID: 14580213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na+-H+ exchanger regulatory factor 1 (NHERF1) PDZ scaffold binds an internal binding site in the scavenger receptor megalin.
    Slattery C; Jenkin KA; Lee A; Simcocks AC; McAinch AJ; Poronnik P; Hryciw DH
    Cell Physiol Biochem; 2011; 27(2):171-8. PubMed ID: 21325834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins.
    Hall RA; Ostedgaard LS; Premont RT; Blitzer JT; Rahman N; Welsh MJ; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8496-501. PubMed ID: 9671706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface.
    Lazar CS; Cresson CM; Lauffenburger DA; Gill GN
    Mol Biol Cell; 2004 Dec; 15(12):5470-80. PubMed ID: 15469991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration.
    James MF; Beauchamp RL; Manchanda N; Kazlauskas A; Ramesh V
    J Cell Sci; 2004 Jun; 117(Pt 14):2951-61. PubMed ID: 15161943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
    Yuan Y; Liu H; Sahin A; Dai JL
    Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
    Wang L; Devarajan E; He J; Reddy SP; Dai JL
    Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange.
    Hall RA; Premont RT; Chow CW; Blitzer JT; Pitcher JA; Claing A; Stoffel RH; Barak LS; Shenolikar S; Weinman EJ; Grinstein S; Lefkowitz RJ
    Nature; 1998 Apr; 392(6676):626-30. PubMed ID: 9560162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
    Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
    Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
    Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
    Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.